Tamotreat 10 Tablet contains Tamoxifen 10mg, a selective estrogen receptor modulator (SERM) widely used in the treatment and prevention of hormone receptor-positive breast cancer. It helps in reducing tumor growth by blocking estrogen activity in breast tissue.
Tamoxifen works by binding to estrogen receptors, preventing estrogen from stimulating cancer cell proliferation. This mechanism helps in controlling disease progression and supporting long-term management in breast cancer patients.
This tablet is commonly prescribed for adjuvant therapy in early and advanced breast cancer, as well as for risk reduction in high-risk patients. Its oral dosage offers convenience, improves compliance, and ensures sustained therapy.
For PCD pharma franchise partners, Tamotreat 10 Tablet is a high-demand oncology product, available at the best price for PCD pharma franchise. With rising awareness and consistent prescription trends, it represents a valuable addition to any cancer-care product portfolio.
Common side effects may include hot flashes, nausea, fatigue, mild menstrual irregularities, and fluid retention. Rare but serious side effects include blood clots, stroke, endometrial cancer, or vision disturbances. Any unusual or severe symptoms should be reported to a doctor immediately.
Tamotreat 10 Tablet is indicated for the treatment of hormone receptor-positive breast cancer in premenopausal and postmenopausal women, as well as for reducing the risk of breast cancer in high-risk individuals, as prescribed by a healthcare professional.
Tamotreat 10 Tablet should be taken exactly as prescribed, usually once daily. Regular monitoring by a healthcare professional is recommended, including liver function tests and gynecological check-ups. Inform the doctor of any history of blood clots, liver disease, or cardiovascular issues.
Store Tamotreat 10 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date on the packaging.